Oleocanthal Protects C2C12 Myotubes against the Pro-Catabolic and Anti-Myogenic Action of Stimuli Able to Induce Muscle Wasting In Vivo

Daniela De Stefanis,Andrea Balestrini,Paola Costelli
DOI: https://doi.org/10.3390/nu16091302
IF: 5.9
2024-04-27
Nutrients
Abstract:Oleocanthal (OC) is a monophenol of extra-virgin olive oil (EVOO) endowed with antibiotic, cardioprotective and anticancer effects, among others, mainly in view of its antioxidant and anti-inflammatory properties. OC has been largely investigated in terms of its anticancer activity, in Alzheimer disease and in collagen-induced arthritis; however, the possibility that it can also affect muscle biology has been totally overlooked so far. This study is the first to describe that OC modulates alterations induced in C2C12 myotubes by stimuli known to induce muscle wasting in vivo, namely TNF-α, or in the medium conditioned by the C26 cachexia-inducing tumor (CM-C26). C2C12 myotubes were exposed to CM-C26 or TNF-α in the presence or absence of OC for 24 and 48 h and analyzed by immunofluorescence and Western blotting. In combination with TNF-α or CM-C26, OC was revealed to be able to restore both the myotube's original size and morphology and normal levels of both atrogin-1 and MuRF1. OC seems unable to impinge on the autophagic–lysosomal proteolytic system or protein synthesis. Modulations towards normal levels of the expression of molecules involved in myogenesis, such as Pax7, myogenin and MyHC, were also observed in the myotube cultures exposed to OC and TNF-α or CM-C26. In conclusion, the data presented here show that OC exerts a protective action in C2C12 myotubes exposed to TNF-α or CM-C26, with mechanisms likely involving the downregulation of ubiquitin–proteasome-dependent proteolysis and the partial relief of myogenic differentiation impairment.
nutrition & dietetics
What problem does this paper attempt to address?
The problem this paper attempts to address is the protective effect of Oleuropein (OC) on C2C12 myotubes under muscle atrophy-inducing conditions. Specifically, the study investigates whether OC can alleviate the myotube atrophy effects induced by the pro-inflammatory cytokine TNF-α or by the conditioned medium of cachexia-inducing C26 tumor cells (CM-C26). The experimental results indicate that OC can partially restore the morphology of myotubes and downregulate the expression levels of muscle-specific ubiquitin ligases (atrogin-1 and MuRF1) induced by TNF-α and CM-C26, thereby potentially protecting myotubes from damage by inhibiting the ubiquitin-proteasome-dependent protein degradation pathway. Additionally, OC also exhibits regulatory effects on the expression of myogenic markers, including molecules such as Pax7, myogenin, and MyHC, demonstrating its potential in improving myogenic differentiation disorders. Overall, this paper reveals the mechanisms and effects of OC as a potential muscle-protective agent in combating muscle atrophy.